NCT05042609 Phase 3 Completed
A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma Study sponsor: Tarsier Pharma
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2023-06-29 Actual
Enrollment · participants 142 Actual
Source updated 2026-05-20 Last update listed in the registry record
Version history
Changes to this trial Last 12 months
Posted 2025-11-10 · 1 field changed
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before Measure: Anterior Chamber Cell (ACC) Grade on Day 28
+ After Measure: Anterior Chamber Cell (ACC) Grade = 0 on Day 28
Measure: Anterior Chamber Cell (ACC) Grade = 0 or 1 on Day 28
Check registry source
This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology
Trial